Pharmaceutical

NHS rolls out “more convenient” Ocrevus injection for multiple sclerosis

The subcutaneous formulation of Roche’s blockbuster Ocrevus will cut hospital treatment time for patients.

Jul 14, 2024 - 04:00
NHS rolls out “more convenient” Ocrevus injection for multiple sclerosis
The subcutaneous formulation of Roche’s blockbuster Ocrevus will cut hospital treatment time for patients.
Read the original article

Tags:

Previous Article

Explainer: Labour has been elected in the UK – now what?

Next Article

Ipsen gains global rights to Foreseen Biotech’s FS001 ADC

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Recordati to acquire worldwide rights to Sanofi’s antibody Enjaymo

Recordati to acquire worldwide rights to Sanofi’s antib...

Oct 6, 2024

STAT+: Pharmalittle: Opaque conflicts permeate prescription drug benefits; Sanofi prevails in Zantac arbitration

STAT+: Pharmalittle: Opaque conflicts permeate prescrip...

Jun 20, 2023

Janssen’s Talvey adds European approval on top of its US authorisation

Janssen’s Talvey adds European approval on top of its U...

Aug 22, 2023